Viewing Study NCT03642132

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:36 PM
Ignite Modification Date: 2026-04-04 @ 11:25 AM
Study NCT ID: NCT03642132
Status: TERMINATED
Last Update Posted: 2023-04-06
First Post: 2018-07-13
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None untreated epithelial ovarian cancer View
None fallopian tube cancer View
None primary peritoneal cancer View